エーザイ、臨床第III相Clarity AD試験データを用いた「レカネマブ」の長期的健康アウトカムについて、シミュレーションを用いた評価結果が査読学術専門誌Neurology and Therapy誌に掲載 Eisai Apr 04, 2023 12:00 JST Read More
Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022 Peijia Medical Ltd Apr 03, 2023 14:52 HKT/SGT Read More
Eisai Enters Into Agreement With National Cancer Center to Collaborate on Investigator-Initiated Clinical Research for Anticancer Agent Tazemetostat Based on "Patient-Proposed Healthcare Services" System Eisai Apr 03, 2023 12:06 HKT/SGT Read More
Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition Avantor Apr 03, 2023 12:00 HKT/SGT Read More
Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition Avantor Apr 03, 2023 11:53 HKT/SGT Read More
エーザイ、抗がん剤タゼメトスタットについて、「患者申出療養」制度に基づく医師主導臨床研究への協力に関する契約を国立がん研究センターと締結 Eisai Apr 03, 2023 10:00 JST Read More
Sino Biopharm (1177.HK) Announces 2022 Annual Results Sino Biopharmaceutical Limited Mar 31, 2023 21:11 HKT/SGT Read More
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator AcroMeta Group Limited Mar 31, 2023 20:15 HKT/SGT Read More
Eisai Presented New Analyses of Aria and QOL on Lecanemab in Clarity AD at the AD/PD 2023 Annual Meeting Eisai Mar 31, 2023 15:51 HKT/SGT Read More
Eisai: Additional Detailed Analyses from Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals Eisai Mar 31, 2023 13:55 HKT/SGT Read More
Ocumension Therapeutics Announces 2022 Annual Results Ocumension Therapeutics Mar 30, 2023 22:29 HKT/SGT Read More
冠科美博(Apollomics Inc.)宣布完成和SPAC Maxpro合并,并在纳斯达克上市 Apollomics, Inc. Mar 30, 2023 20:31 HKT/SGT Read More
冠科美博(Apollomics Inc.)宣佈完成和SPAC Maxpro合併,並在納斯達克上市 Apollomics, Inc. Mar 30, 2023 20:30 HKT/SGT Read More